Not finding it? Sign in to also search OpenAlex live.
-
Budget impact analysis of medication reviews by junior pharmacists in polypharmacy patients: a hospital perspective2026 International Journal of Clinical Pharmacy article Medicine Pharmaceutical Practices and Patient Outcomes Open access
Toon Hectors, Thirza Kooijman, Marit van Barreveld, Marianne A. Kuijvenhoven, Patty J I Teeuwisse, Rik Olde Engberink
0citations -
Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines2024 Frontiers in Pharmacology editorial Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access
Atse H Huisman, Denise van den Berg, Saco J. de Visser, Bettina Ryll, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani
0citations -
Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors2023 Genes article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Amar D. Levens, Melina C. den Haan, J. Wouter Jukema, Mette Heringa, Wilbert B. van den Hout, Dirk Jan A. R. Moes, +1 more
11citations -
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis2022 Journal of Medical Internet Research article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access
Rawa Kamaran Ismail, Jesper van Breeschoten, S. van der Flier, Caspar van Loosen, Anna M.G. Pasmooij, Maaike van Dartel, +4 more
3citations -
Barriers, facilitators, and implementation strategies for pharmacogenomics in community pharmacies: a cross-sectional survey among local champions in pharmacies and key opinion leaders in pharmacogenomics2025 International Journal of Clinical Pharmacy article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Pantea Kiani, Pierre M. Bet, Naomi T. Jessurun, Petra Hoogland, Jesse Joachim Swen, Sander Diederik Borgsteede
4citations -
Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States2023 Journal of Managed Care & Specialty Pharmacy article Medicine Urinary Tract Infections Management Open access
Luis Hernandez-Pastor, Jeroen Geurtsen, Bryan Baugh, Antoine C. El Khoury, Nnanya U. Kalu, Girishanthy Krishnarajah, +4 more
9citations -
Chancen und Herausforderungen der Digitalisierung der Arzneimittelversorgung: eine qualitative Studie mit relevanten ExpertInnen2025 Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen article Business, Management and Accounting Digital Innovation in Industries Open access
Christopher Johannes Preetz, Michaela Hesse, Martin Mücke, Gülay Ateş
0citations -
Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs2023 European Journal of Hospital Pharmacy article Health Professions Safe Handling of Antineoplastic Drugs Open access
Tjerk H Geersing, Demelza M Pourahmad, Femke Lodewijk, Eric J. F. Franssen, Catherijne A. J. Knibbe, Mirjam Crul
8citations -
NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines2025 Frontiers in Science article Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery Open access
Mariona Estapé Sentí, Alexandre Ceccaldi, Nadine Saber, Paul J. L. Schürmann, Maurits Geerlings, Peter Hölig, +15 more
16citations -
Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation
Peter J. C. Stuijt, Mette Heringa, Liset van Dijk, Adrianne Faber, Jako S. Burgers, Talitha Feenstra, +2 more
7citations
20 results